Volume 7, Issue 4
مرور بر اساس
ارسال های اخیر
- 
Autoimmune Lymphoproliferative Syndrome Misdiagnosed as Hemophagocytic Lymphohistiocytosis A Case Report (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Autoimmune lymphoproliferative Syndrome (ALPS) is a rare inherited disorder of apoptosis. It usually presents with chronic lymphadenopathy, splenomegaly, and symptomatic cytopenia in a child. Herein, we report a 14-year-old ...
 
- 
Neuroendocrine Carcinoma of the Stomach A Case Report (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Gastric neuroendocrine carcinoma is a rare tumor which has a poor prognosis. Herein, we present a 55-year-old woman who presented with complaints of recurrent vomiting, hematemesis and weight loss. Endoscopic examination ...
 
- 
Analysis of Expression Of SIRT1 Gene In Patients With Chronic Myeloid Leukemia Resistant To Imatinib Mesylate (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Background: Chronic myeloid leukemia is a clonal myeloproliferative disease which is characterized by bcr/abl translocation. With the emergence of tyrosine kinase inhibitors such as imatinib mesylate, significant improvement ...
 
- 
The Survey of Effective Agents on Factor VIII and IX Inhibitors in Patients with Hemophilia A and B in Kermanshah Province (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Background: Hemophilia is the most frequent severe hereditary hemorrhagic disease due to deficiency of coagulation factors VIII (Hemophilia A) or IX (Hemophilia B) in plasma. We aimed to identify patients with hemophilia ...
 
- 
Is There any Association between Thyroid Autoimmunity and Breast Cancer? (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Background: The relationship between thyroid autoimmunity and breast cancer is a challenging subject. We aimed to investigate this association in women with breast cancer. Methods: In this descriptive study, 41 women with ...
 
- 
A prospective Crossover Triple-blind Controlled Trial on the Safety and Efficacy of Iranian Recombinant FVIII (Safacto) versus Plasma Derived FVIII A pilot study (Tehran, Iranian Blood and Cancer Society, 2015-07-01)Background: Considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. The objective of this study ...
 
- 
Complete Content of this Issue and Cover Content (Tehran, Iranian Blood and Cancer Society, 2015-07-01)
 



